reference/347179

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/347179

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	1089
issn	0302-2838
issueIdentifier	4
pageRange	1082-1089
publicationName	European Urology
startingPage	1082
bibliographicCitation	Cussenot O, Azzouzi AR, Nicolaiew N, Mangin P, Cormier L, Fournier G, Valeri A, Cancel-Tassin G. Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors. Eur Urol. 2007 Oct;52(4):1082–7. doi: 10.1016/j.eururo.2007.04.008. PMID: 17448593.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dbc43ffd0c2b879ca54ee84da40b9b82 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2098c3d9567a0035193d5c5b0009ffe5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2e61a8bab0c8525e61802f8eb4891991 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_59965a1c0ac6437b9645b02f0c2d1610 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9912-0533 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_582d86d50371748bf59c359dc6319651 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb89d1d09e334c5b487fcbf495891284 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0fd18bc4113e9bf211c691e81a9cd55b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_480f3ceccf1ee2d21d3619fa56469db6
date	200710
identifier	https://pubmed.ncbi.nlm.nih.gov/17448593 https://doi.org/10.1016/j.eururo.2007.04.008
isPartOf	https://portal.issn.org/resource/ISSN/0302-2838 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3630
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Low-Activity V89L Variant in SRD5A2 Is Associated with Aggressive Prostate Cancer Risk: An Explanation for the Adverse Effects Observed in Chemoprevention Trials Using 5-Alpha-Reductase Inhibitors
discusses	http://id.nlm.nih.gov/mesh/M0072874 http://id.nlm.nih.gov/mesh/M0012835 http://id.nlm.nih.gov/mesh/M0022497 http://id.nlm.nih.gov/mesh/M0021199 http://id.nlm.nih.gov/mesh/M0007520
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014644 http://id.nlm.nih.gov/mesh/D011471Q000235 http://id.nlm.nih.gov/mesh/D004791Q000009 http://id.nlm.nih.gov/mesh/D013741Q000235 http://id.nlm.nih.gov/mesh/D042944Q000037 http://id.nlm.nih.gov/mesh/D019943 http://id.nlm.nih.gov/mesh/D011471Q000473
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D018890 http://id.nlm.nih.gov/mesh/D013741Q000378 http://id.nlm.nih.gov/mesh/D005838 http://id.nlm.nih.gov/mesh/D011471Q000201 http://id.nlm.nih.gov/mesh/D017211 http://id.nlm.nih.gov/mesh/D008239 http://id.nlm.nih.gov/mesh/D004791Q000627 http://id.nlm.nih.gov/mesh/D014633 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5f0f0ae21b7e6c9e5eebadaafdf6777d http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6013 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7025 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57363 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10635 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6716 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128649586 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128760372 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128773150 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128458032 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128368393

Total number of triples: 63.